UnitedHealth's stock is plunging on higher medical costs. That may mean trouble for more insurers
23andMe bankruptcy under congressional investigation for customer data
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Abbott Labs shares surge on earnings and a big sign of confidence in the business
Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs
Medical product manufacturers are divided over Trump's tariffs
CDC says measles cases are most likely underreported as outbreak swells in Texas
Pfizer scraps daily weight loss pill after liver injury in one patient
